JPRN-UMIN000012948招募中2 期
Phase II randomized study to investigate the effectiveness of Hangeshashinto(TJ-14) against chemoradiation-induced oral and pharyngeal mucositis - A rondomized study to investigate the effectiveness of Hangeshashinto(TJ-14) against chemoradiation-induced oral mucositis
Department of Otolaryngolory-Head and Neck Surgery, National Defense Medical College of Japan0 个研究点目标入组 90 人开始时间: 2014年1月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients administered other Kampo medicine within 2 weeks before registration 2) Patients who were continuously adminisiterd NSAIDs, opioids or steroids within one month before registration 3) Patients having serious comorbid disease 4) Patients administered a developing new drug 5) Pregnant patients
研究者
相似试验
进行中（未招募）
不适用
A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer - NDEUCTR2005-005048-19-ITISTITUTO EUROPEO DI ONCOLOGIA120
招募中
2 期
A study on the efficacy and safety of cisplatin/etoposide and concomitant radiotherapy in combination with durvalumab, an immunotherapy, in patients with local limited small cell lung cancer2024-513433-20-00Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR105
招募中
2 期
A study in HIV infected blood cancer patients to know to test two types of chemotherapy regimen. Patients will be divided in two equal groups for testing purpose.CTRI/2020/10/028220Tata Memorial Hospital Research Administrative Council
进行中（未招募）
1 期
A randomized phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)Salivary gland cancerMedDRA version: 17.0Level: PTClassification code 10061934Term: Salivary gland cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000314-38-FREuropean Organisation for Research and Treatment of Cancer (EORTC)452
进行中（未招募）
1 期
A randomized phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)EUCTR2013-000314-38-NLEuropean Organisation for Research and Treatment of Cancer (EORTC)220